Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DGX · NYSE · Health Care Services
Quest Diagnostics (DGX) · oqro.io/stocks/DGX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$258.28−0.81 (−0.31%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$1.63M of DGX shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$1.43M of DGX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a reduced position in DGX for Q3 2026SourceInsider trade · Traded Nov 9, 2026 · Filed Nov 13, 2026
Officer sold ~$1.75M of DGX shares in the open marketSourceInsider trade · Traded Nov 9, 2026 · Filed Nov 13, 2026
Officer sold ~$1.1M of DGX shares in the open marketSourceInsider trade · Traded Nov 9, 2026 · Filed Nov 13, 2026
Officer sold ~$167K of DGX shares in the open marketSourcePlanned sale · Planned for Nov 9, 2026 · Notice filed Nov 9, 2026
Officer filed to sell about $3.02M of DGX stockSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$1.48M of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$937K of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$749K of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$721K of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$730K of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$586K of DGX shares in the open marketSourceInsider trade · Traded Nov 3, 2026 · Filed Nov 6, 2026
Officer sold ~$284K of DGX shares in the open marketSourcePlanned sale · Planned for Nov 3, 2026 · Notice filed Nov 3, 2026
Officer filed to sell about $5.58M of DGX stockSourceInsider trade · Traded Oct 26, 2026 · Filed Oct 28, 2026
Director sold ~$292K of DGX shares in the open marketSourcePlanned sale · Planned for Oct 26, 2026 · Notice filed Oct 26, 2026
Director filed to sell about $292K of DGX stockSourceFederal contract · Signed Oct 1, 2026 · Updated Oct 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $7.16M obligated to dateSourceFederal contract · Signed Oct 1, 2026 · Updated Oct 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $3.11M obligated to dateSourceFederal contract · Signed Sep 29, 2026 · Updated Sep 29, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $3.5M obligated to dateSourceInsider trade · Traded Sep 1, 2026 · Filed Sep 3, 2026
CEO sold ~$2.43M of DGX shares in the open marketSourceInsider trade · Traded Aug 28, 2026 · Filed Aug 31, 2026
Officer sold ~$3.89M of DGX shares in the open marketSourceInsider trade · Traded Aug 28, 2026 · Filed Aug 31, 2026
Officer sold ~$1.52M of DGX shares in the open marketSourceInsider trade · Traded Aug 28, 2026 · Filed Aug 31, 2026
Officer sold ~$105K of DGX shares in the open marketSourceFederal contract · Signed Mar 24, 2026 · Updated Aug 21, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $6.57M obligated to dateSourceInsider trade · Traded Jul 28, 2026 · Filed Jul 29, 2026
Officer sold ~$376K of DGX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 23, 2026
Artemis Investment Management LLP disclosed an increased position in DGX for Q2 2026SourcePolitician trade (Senate) · Transaction Mar 30, 2026 · Disclosed Jul 21, 2026
Disclosed purchase of DGX — reported range $1,001 - $15,000SourcePolitician trade (Senate) · Transaction Mar 27, 2026 · Disclosed Jul 21, 2026
Disclosed purchase of DGX — reported range $1,001 - $15,000SourceInsider trade · Traded Jun 4, 2026 · Filed Jun 8, 2026
Officer sold ~$1.63M of DGX shares in the open marketSourceInsider trade · Traded Jun 1, 2026 · Filed Jun 2, 2026
CEO sold ~$1.94M of DGX shares in the open marketSourceFederal contract · Signed Apr 1, 2026 · Updated Jun 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $3.12M obligated to dateSourceFederal contract · Signed May 1, 2026 · Updated Jun 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $2.6M obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
EdgePoint Investment Group Inc. disclosed an increased position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Clark Capital Management Group, Inc. disclosed a new position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Freestone Grove Partners LP disclosed a reduced position in DGX for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 13, 2026
Artemis Investment Management LLP disclosed a reduced position in DGX for Q1 2026SourceFederal contract · Signed Apr 2, 2026 · Updated Apr 2, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $2.71M obligated to dateSourceInsider trade · Traded Mar 5, 2026 · Filed Mar 6, 2026
Officer sold ~$1.15M of DGX shares in the open marketSourceInsider trade · Traded Mar 5, 2026 · Filed Mar 6, 2026
Officer sold ~$800K of DGX shares in the open marketSourceInsider trade · Traded Mar 5, 2026 · Filed Mar 6, 2026
Officer sold ~$589K of DGX shares in the open marketSourceInsider trade · Traded Mar 4, 2026 · Filed Mar 6, 2026
Officer sold ~$538K of DGX shares in the open marketSourceInsider trade · Traded Feb 19, 2026 · Filed Feb 20, 2026
Officer sold ~$294K of DGX shares in the open marketSourceInsider trade · Traded Feb 19, 2026 · Filed Feb 20, 2026
Officer sold ~$228K of DGX shares in the open marketSourceInsider trade · Traded Feb 19, 2026 · Filed Feb 20, 2026
Officer sold ~$196K of DGX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Freestone Grove Partners LP disclosed a new position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 29, 2026
Advisors Capital Management, LLC disclosed an increased position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 29, 2026
Aegon Asset Management UK Plc disclosed a reduced position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 29, 2026
Copeland Capital Management, LLC disclosed a reduced position in DGX for Q4 2025SourceFederal contract · Signed Oct 1, 2026 · Updated Oct 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $2.7M obligated to dateSourceFederal contract · Signed Oct 1, 2026 · Updated Oct 1, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $2.7M obligated to dateSource5%+ stake · Stake as of Jun 30, 2026 · Filed Aug 14, 2026
T. Rowe Price Associates, Inc. cut its DGX stake below 5% (4.9%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Crawford Investment Counsel Inc disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Van Lanschot Kempen Investment Management N.V. disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in DGX for Q2 2026SourcePolitician trade (House) · Transaction Mar 10, 2025 · Disclosed Aug 13, 2026
Disclosed sale of DGX — reported range $15,001 - $50,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Fiduciary Management Inc disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Davis Selected Advisers disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Clark Capital Management Group, Inc. disclosed an increased position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 6, 2026
Antipodes Partners Ltd disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 6, 2026
M&G PLC disclosed a reduced position in DGX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 6, 2026
ABN AMRO Bank N.V. disclosed an increased position in DGX for Q2 2026SourcePolitician trade (House) · Transaction Oct 30, 2025 · Disclosed Aug 5, 2026
Disclosed purchase of DGX — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Oct 30, 2025 · Disclosed Aug 5, 2026
Disclosed sale of DGX — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 4, 2026
Copeland Capital Management, LLC disclosed a reduced position in DGX for Q2 2026SourceFederal contract · Signed Oct 28, 2025 · Updated Jul 14, 2026
Department of Veterans Affairs awarded Quest Diagnostics: $2.75M obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Crawford Investment Counsel Inc disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Van Lanschot Kempen Investment Management N.V. disclosed an increased position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
CSM Advisors, LLC disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Fiduciary Management Inc disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Grantham, Mayo, Van Otterloo & Co. LLC disclosed an increased position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
M&G PLC disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Tocqueville Asset Management L.P. disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 7, 2026
Davis Selected Advisers disclosed an increased position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 6, 2026
Copeland Capital Management, LLC disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 5, 2026
Antipodes Partners Ltd disclosed a reduced position in DGX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 1, 2026
Advisors Capital Management, LLC disclosed an increased position in DGX for Q1 2026SourceInsider trade · Traded Mar 2, 2026 · Filed Mar 4, 2026
CEO sold ~$2.13M of DGX shares in the open marketSourceInsider trade · Traded Mar 3, 2026 · Filed Mar 4, 2026
Officer sold ~$131K of DGX shares in the open marketSourceInsider trade · Traded Mar 3, 2026 · Filed Mar 4, 2026
Officer sold ~$109K of DGX shares in the open marketSourceInsider trade · Traded Mar 3, 2026 · Filed Mar 4, 2026
Officer sold ~$85K of DGX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
EdgePoint Investment Group Inc. disclosed an increased position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP no longer reported DGX for Q4 2025SourceInsider trade · Traded Feb 13, 2026 · Filed Feb 17, 2026
Officer sold ~$2.17M of DGX shares in the open marketSourceInsider trade · Traded Feb 13, 2026 · Filed Feb 17, 2026
Officer sold ~$2.09M of DGX shares in the open marketSourceInsider trade · Traded Feb 13, 2026 · Filed Feb 17, 2026
Officer sold ~$725K of DGX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Grantham, Mayo, Van Otterloo & Co. LLC disclosed an increased position in DGX for Q4 2025SourceInsider trade · Traded Feb 13, 2026 · Filed Feb 17, 2026
Officer sold ~$337K of DGX shares in the open marketSourceInsider trade · Traded Feb 13, 2026 · Filed Feb 17, 2026
Officer sold ~$73K of DGX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a reduced position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Van Lanschot Kempen Investment Management N.V. disclosed a reduced position in DGX for Q4 2025SourceInsider trade · Traded Feb 10, 2026 · Filed Feb 12, 2026
Officer sold ~$1.16M of DGX shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 12, 2026
M&G PLC disclosed a reduced position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
Fiduciary Management Inc disclosed a reduced position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
CSM Advisors, LLC disclosed an increased position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 6, 2026
Abn Amro Investment Solutions disclosed a reduced position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 5, 2026
Antipodes Partners Ltd disclosed an increased position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Davis Selected Advisers disclosed an increased position in DGX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 2, 2026
Artemis Investment Management LLP disclosed an increased position in DGX for Q4 2025Source